Literature DB >> 9135502

Expression of neural BC1 RNA: induction in murine tumours.

W Chen1, J Heierhorst, J Brosius, H Tiedge.   

Abstract

BC1 RNA is a small cytoplasmic RNA polymerase III transcript that is expressed in the rodent nervous system. The RNA is selectively expressed in neurons where it is located in somatodendritic domains. BC1 RNA is not normally detectable in non-neuronal somatic cells; it is however expressed in germ cells and in cultured immortal cell lines of various non-neural origins. We therefore sought to establish whether the neuron-specific regulation of BC1 expression is altered in non-neural tumour cells. Oncogen and chemical carcinogen induced mouse tumours were analysed for the presence of BC1 RNA, using Northern transfer and in situ hybridisation. Here we report that BC1 RNA is selectively expressed in tumour cells, but not in corresponding normal tissues. These results indicate that neural-specific regulation of BC1 expression is lacking in murine tumour cells of non-neural origin.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9135502     DOI: 10.1016/s0959-8049(96)00453-4

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  10 in total

1.  Cis-acting influences on Alu RNA levels.

Authors:  C Alemán; A M Roy-Engel; T H Shaikh; P L Deininger
Journal:  Nucleic Acids Res       Date:  2000-12-01       Impact factor: 16.971

Review 2.  RNA polymerase III transcription: its control by tumor suppressors and its deregulation by transforming agents.

Authors:  T R Brown; P H Scott; T Stein; A G Winter; R J White
Journal:  Gene Expr       Date:  2000

3.  Overexpression of initiator methionine tRNA leads to global reprogramming of tRNA expression and increased proliferation in human epithelial cells.

Authors:  Mariana Pavon-Eternod; Suzana Gomes; Marsha R Rosner; Tao Pan
Journal:  RNA       Date:  2013-02-19       Impact factor: 4.942

4.  RNA polymerase III transcription factor TFIIIC2 is overexpressed in ovarian tumors.

Authors:  A G Winter; G Sourvinos; S J Allison; K Tosh; P H Scott; D A Spandidos; R J White
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

5.  Enhanced RNA polymerase III-dependent transcription is required for oncogenic transformation.

Authors:  Sandra A S Johnson; Louis Dubeau; Deborah L Johnson
Journal:  J Biol Chem       Date:  2008-05-01       Impact factor: 5.157

6.  Epidermal growth factor receptor 1 (EGFR1) and its variant EGFRvIII regulate TATA-binding protein expression through distinct pathways.

Authors:  Jody A Fromm; Sandra A S Johnson; Deborah L Johnson
Journal:  Mol Cell Biol       Date:  2008-08-18       Impact factor: 4.272

7.  PTEN represses RNA polymerase III-dependent transcription by targeting the TFIIIB complex.

Authors:  Annette Woiwode; Sandra A S Johnson; Shuping Zhong; Cheng Zhang; Robert G Roeder; Martin Teichmann; Deborah L Johnson
Journal:  Mol Cell Biol       Date:  2008-04-07       Impact factor: 4.272

8.  miRNA deregulation targets specific pathways in leiomyosarcoma development: an in silico analysis.

Authors:  Clara Benna; Senthilkumar Rajendran; Marco Rastrelli; Simone Mocellin
Journal:  J Transl Med       Date:  2019-05-14       Impact factor: 5.531

9.  tRNA over-expression in breast cancer and functional consequences.

Authors:  Mariana Pavon-Eternod; Suzanna Gomes; Renaud Geslain; Qing Dai; Marsha Rich Rosner; Tao Pan
Journal:  Nucleic Acids Res       Date:  2009-11       Impact factor: 16.971

10.  RNAi and cancer: Implications and applications.

Authors:  Maen Abdelrahim; Stephen Safe; Cheryl Baker; Ala Abudayyeh
Journal:  J RNAi Gene Silencing       Date:  2006-02-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.